Propafenone Production Cost Reports

The report provides a detailed analysis essential for establishing a Propafenone production plant. It encompasses all critical aspects necessary for Propafenone production, including the cost of Propafenone production, Propafenone plant cost, Propafenone production costs, and the overall Propafenone production plant cost. Additionally, the study covers specific expenditures associated with setting up and operating a Propafenone production plant. These encompass production processes, raw material requirements, utility requirements, infrastructure needs, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, and more.

Propafenone is an antiarrhythmic drug that works by stabilising the heart's electrical activity to correct irregular heart rhythms. It is used to treat sudden or recurring episodes of atrial fibrillation or atrial flutter, where the upper chambers of the heart beat chaotically and rapidly. It is used in patients who do not have underlying structural heart problems like damaged heart muscle or valves.

It slows down the electrical signals in the atria and helps extend the time between these episodes, reducing symptoms like palpitations, dizziness, or fatigue. It is also prescribed for life-threatening ventricular arrhythmias, including sustained ventricular tachycardia. Its common side effects include dizziness, nausea, vomiting, metallic taste, fatigue, constipation, diarrhoea, headache, rash, blurred vision, and dry mouth.

The market for Propafenone is driven by the rising global prevalence of cardiac arrhythmias. The increasing ageing populations, growing cases of cardiovascular diseases, and awareness of effective antiarrhythmic treatments boost its demand. The adoption of generic versions in developing markets and technological improvements in production that reduce costs expand its applications.

Also, supportive government policies promoting affordable generics alongside growing demand from hospitals and clinics, fuel its market further. The industrial Propafenone procurement is influenced by securing high-purity API, strict regulatory compliance like GMP, USDMF, or CEP certifications. Also, reliable supplier networks and pricing dynamics influenced by raw material costs, complex synthesis processes, supply chain stability, and environmental regulations affect its sourcing strategies.

Raw Material for Propafenone Production

According to the Propafenone production plant project report, the key raw materials used in the production of Propafenone include Phenol, 3-phenylpropionyl chloride, and Epichlorohydrin.

Production Process of Propafenone

The extensive Propafenone production cost report consists of the following major industrial production process:

1. From Friedel-Crafts Acylation: The production process of Propafenone starts with Friedel-Crafts acylation of phenol using 3-phenylpropionyl chloride. The reaction takes place in the presence of a Lewis acid catalyst like aluminium chloride to produce the intermediate 1-(2-hydroxyphenyl)-3-phenyl-1-propanone. This phenolic ketone then reacts with epichlorohydrin under basic conditions to form the glycidyl ether intermediate through etherification and epoxide ring formation. The final step leads to nucleophilic ring-opening of this epoxide with propylamine, followed by acidification with hydrochloric acid to yield propafenone hydrochloride as the stable salt.

Propafenone has the molecular formula of C21H27NO3 and a molecular weight of 341.44 g/mol. It appears as a white to off-white crystalline powder to form a lipophilic weak base. It is sparingly soluble in water but highly soluble in organic solvents like DMSO and ethanol. It has a boiling point near 520 degree Celsius and a density of around 1.10 g/cm³. The hydrochloride salt is commonly used pharmaceutically and has a melting point of 171-175 degree Celsius. It remains stable under refrigeration (2-8 degree Celsius), and shows collision cross sections of 176-184 Ų for protonated ions. Its racemic structure features (R)- and (S)-enantiomers with stereoselective metabolism, where the S-form provides potent beta-blockade.